Clinical Trial

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

Study acronym: MC-RWE
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-03 -> 2028-03 2026-07-23
minor Completion pushed: 2027-07 -> 2028-07 2026-07-23
Trial Details
NCT Number NCT04526093
Lead Sponsor University Health Network, Toronto
Collaborators: Avicanna Inc
Conditions Pain, Sleep, Anxiety, Depression, Epilepsy
Enrollment 1,000 participants
Start Date 2020-07-15
Primary Completion 2028-03 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-22